Literature DB >> 10747765

Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.

E J Beck1, S Mandalia, R Griffith, J Beecham, M D Walters, M Boulton, D L Miller.   

Abstract

OBJECTIVE: To describe the use of hospital and community services for children infected with HIV and estimate the cost per patient-year by stage of HIV infection during the era of antiretroviral monotherapy.
DESIGN: Data on the use of hospital services were collected from case notes; the use of statutory and nonstatutory community services was recorded through diaries and interviews. Total cost estimates were calculated from unit costs from relevant hospital departments and community organisations.
SETTING: Children managed at St. Mary's Hospital (London, England) between 1 January 1986 and 31 December 1994, some of whom used statutory and nonstatutory community services in South East England between 1 November 1994 and 31 May 1996. PATIENTS AND PARTICIPANTS: 118 children with positive HIV antibody status. MAIN OUTCOME MEASURES AND
RESULTS: Mean inpatient days, outpatient visits, tests and procedures performed, drugs prescribed, community services used, associated unit costs and average cost estimates per patient-year by stage of HIV infection (1995/1996 values), and lifetime costs. Service provision during the study period was predominantly hospital-based. The use of services increased for different stages of HIV infection and increased with increasing severity of HIV infection. A shift from an inpatient-based to an outpatient-based service was seen between the periods 1986 to 1991 and 1992 to 1994. As symptoms evolved, children used more hospital inpatient services, with an accompanying shift in the use of community services from general services, such as schooling, to increased use of nurses, social care and home help. The estimated total cost of hospital and community care was 18,600 Pounds per symptomatic non-AIDS patient per year and 46,600 Pounds per AIDS patient per year. Similar estimates for children with indeterminate HIV infection and asymptomatic infection amounted to 8300 Pounds and 4800 Pounds per patient-year, respectively. Nondiscounted lifetime costs for hospital care amounted to 152,400 Pounds (44,300 Pounds to 266,800 Pounds) compared with discounted lifetime costs of 122,700 Pounds (42,000 Pounds to 182,200 Pounds); nondiscounted lifetime costs for community care amounted to 24,300 Pounds (7900 Pounds to 41,600 Pounds) compared with discounted lifetime costs of 21,000 Pounds (6800 Pounds to 32,000 Pounds).
CONCLUSIONS: The continued emphasis on the use of hospital services may be due to the small number of children infected with HIV, most of whom lived in the London metropolitan area where specialist care was concentrated in a few centres. A shift from an inpatient- to an outpatient-based service was observed over time; the advent of the use of combination antiretroviral therapy in this population may further facilitate a shift in service provision and promote shared care between specialist centres, local hospital and community-based services.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747765     DOI: 10.2165/00019053-200017010-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  23 in total

1.  Protease inhibitor therapy in children with perinatally acquired HIV infection.

Authors:  R M Rutstein; A Feingold; D Meislich; B Word; B Rudy
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

2.  Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1987-04-24       Impact factor: 17.586

3.  Lifetime cost of care for children with human immunodeficiency virus infection.

Authors:  P L Havens; B E Cuene; D R Holtgrave
Journal:  Pediatr Infect Dis J       Date:  1997-06       Impact factor: 2.129

4.  The distinction between cost and charges.

Authors:  S A Finkler
Journal:  Ann Intern Med       Date:  1982-01       Impact factor: 25.391

5.  The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on Costs.

Authors:  E J Beck; K Tolley; A Power; S Mandalia; P Rutter; J Izumi; J Beecham; A Gray; D Barlow; P Easterbrook; M Fisher; J Innes; G Kinghorn; B Mandel; A Pozniak; A Tang; D Tomlinson; I Williams
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

6.  What is the cost of getting the price wrong?

Authors:  E J Beck; J Beecham; S Mandalia; R Griffith; M D Walters; M Boulton; D L Miller
Journal:  J Public Health Med       Date:  1999-09

7.  Changing cost of English HIV service provision 1996-1997. NPMS Steering Group. National Prospective Monitoring System.

Authors: 
Journal:  Int J STD AIDS       Date:  1999-06       Impact factor: 1.359

8.  Modelling the costs of paediatric HIV infection and AIDS: comparison of infected children born to screened and unscreened mothers.

Authors:  M J Sculpher; D Gibb; A E Ades; J Ratcliffe; T Duong
Journal:  AIDS       Date:  1998-07-30       Impact factor: 4.177

9.  Lifetime Medicaid service utilization and expenditures for AIDS in New York and California.

Authors:  R M Andrews; M A Keyes; T R Fanning; K W Kizer
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

10.  Caesarean section and risk of vertical transmission of HIV-1 infection. The European Collaborative Study.

Authors: 
Journal:  Lancet       Date:  1994-06-11       Impact factor: 79.321

View more
  4 in total

Review 1.  The cost of HIV treatment and care. A global review.

Authors:  E J Beck; A H Miners; K Tolley
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

2.  Determinants of health care costs of HIV-positive patients in the Canary Islands, Spain.

Authors:  Juan Oliva-Moreno; Julio López-Bastida; Pedro Serrano-Aguilar; Lilisbeth Perestelo-Pérez
Journal:  Eur J Health Econ       Date:  2010-01-05

3.  Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa.

Authors:  Gesine Meyer-Rath; Alana T Brennan; Matthew P Fox; Tebogo Modisenyane; Nkeko Tshabangu; Lerato Mohapi; Sydney Rosen; Neil Martinson
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

4.  Assessing user preferences for sexually transmitted infection testing services: a discrete choice experiment.

Authors:  Alec Miners; Carrie Llewellyn; Alex Pollard; Mylene Lagarde; Daniel Richardson; John Cairns; Martin Fisher; Helen Smith
Journal:  Sex Transm Infect       Date:  2012-06-01       Impact factor: 3.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.